• Home
  • Pharmacy
    • Learn More
    • Locate a ONE Pharmacy
    • Naloxone
    • Enrollment
    • Workflow Documents
    • Online Training
    • Coaching Calls
    • Opioid Safety Follow-Up
    • Review Modules
    • Frequently Asked Questions
  • Patients & Caregivers
    • Learn More
    • Naloxone
    • Patient Referral Resources
    • Frequently Asked Questions
  • Health Professionals
    • Learn More
    • Home Care
    • Catholic Health Initiatives
    • Essentia Health
    • Public Health Units
    • Frequently Asked Questions
  • Impact & Results
  • Contact Us
    • Get Involved
  • Home
  • Pharmacy
    • Learn More
    • Locate a ONE Pharmacy
    • Naloxone
    • Enrollment
    • Workflow Documents
    • Online Training
    • Coaching Calls
    • Opioid Safety Follow-Up
    • Review Modules
    • Frequently Asked Questions
  • Patients & Caregivers
    • Learn More
    • Naloxone
    • Patient Referral Resources
    • Frequently Asked Questions
  • Health Professionals
    • Learn More
    • Home Care
    • Catholic Health Initiatives
    • Essentia Health
    • Public Health Units
    • Frequently Asked Questions
  • Impact & Results
  • Contact Us
    • Get Involved
Scroll
ONE Program
About

ONE (Opioid and Naloxone Education) is an innovative approach to screen and educate patients who receive prescribed opioid medications at participating community pharmacies in the state of North Dakota.

ONE Program

4 weeks ago

ONE Program

Fentanyl Facts

www.cdc.gov

Fentanyl is a synthetic opioid that is up to 50 times stronger than heroin and 100 times stronger than morphine. It is a major contributor to fatal and nonfatal overdoses in the U.S.1
View on Facebook
· Share

Share on Facebook Share on Twitter Share on Linked In Share by Email

ONE Program

4 weeks ago

ONE Program

Fentanyl Facts

www.cdc.gov

Fentanyl is a synthetic opioid that is up to 50 times stronger than heroin and 100 times stronger than morphine. It is a major contributor to fatal and nonfatal overdoses in the U.S.1
View on Facebook
· Share

Share on Facebook Share on Twitter Share on Linked In Share by Email